Microbix Biosystems Inc. Gets U.S. Flu Vaccine Patent Published: Oct 22, 2007 Microbix Biosystems Inc. (TSX: MBX) has been granted a U.S. patent for its Virusmax influenza vaccine production-enhancement technology. Related links Canadian Press This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news
